Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
In a multinational study involving more than 1,500 patients with complex cardiac profiles, findings revealed no statistically significant difference in the primary outcome of death, myocardial infarction, or unplanned revascularization between FFR-guided complete revascularization and culprit-lesion-only PCI over nearly five years of follow-up.
Cardiology April 19th 2024
MDLinx
With stress tests potentially costing the US healthcare system up to $500 million annually and leading to unwarranted procedures, it’s time to reassess their routine use in asymptomatic patients and consider more accurate diagnostic alternatives.
Cardiology April 3rd 2024
UCSF MedConnection
Leveraging artificial intelligence, the CathEF algorithm offers a groundbreaking method to assess heart function directly from angiogram videos, potentially reducing the need for invasive diagnostics and enhancing patient care strategies.
Cardiology February 26th 2024
In a revealing case of myocardial bridging leading to cardiac arrest, coronary angiography and computed tomographic angiography played pivotal roles in diagnosis and surgical planning, highlighting the anomaly’s late-onset symptomatology in patients with existing cardiovascular conditions.
Cardiology February 7th 2024
British Medical Journal
This study provides valuable insights into the comparative benefits and risks of rosuvastatin and atorvastatin in adults with coronary artery disease. Notably, while both drugs showed comparable efficacy, rosuvastatin was associated with a higher risk of new onset diabetes mellitus and cataract surgery.
Cardiology October 25th 2023